Vitamins With Semaglutide: Biomarker-Guided Nutrition

Last reviewed: May 20, 2026

Last updated: May 20, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Semaglutide significantly reduces appetite and slows gastric emptying, making vitamin and mineral deficiency a real clinical concern. Research shows up to 30% of GLP-1 users develop micronutrient gaps within 6–12 months if supplementation isn't intentional and personalized.

PlexusDx takes a precision-wellness approach: rather than recommending a one-size-fits-all vitamin cocktail, we encourage patients using compounded semaglutide to understand their individual baseline micronutrient status and genetic predispositions to certain deficiencies. This context supports a more informed conversation with your healthcare provider about which supplements truly matter for you.

How Semaglutide Affects Micronutrient Absorption and Status

Semaglutide reduces gastric acid secretion and slows stomach emptying, both of which impair absorption of B12, iron, calcium, and folate. Patients eating 40–50% fewer calories daily face compounded risk of inadequate micronutrient intake even before absorption challenges are considered.

The longer food remains in the stomach, the greater nutrient extraction—but paradoxically, reduced overall food volume means fewer absolute nutrients available. Blood work after 3–6 months on semaglutide often reveals unexpected deficiencies, especially in patients who don't proactively address nutrition.

Priority Micronutrients: Evidence-Based Supplementation Framework

Not all vitamins carry equal clinical urgency. Below is a framework highlighting which micronutrients most commonly decline in semaglutide users and the evidence basis for monitoring or supplementing each one.

Micronutrient	Absorption Risk With Semaglutide	Typical Deficiency Timeline	Provider Monitoring Recommendation
Vitamin B12	High—reduced gastric acid	6–12 months	Baseline and 6-month serum B12 or methylmalonic acid
Iron	High—lower food intake + acid reduction	3–6 months	Ferritin, serum iron, TIBC at baseline and 3 months
Calcium	Moderate—acid-dependent absorption	6–12 months	Serum calcium and 25-OH vitamin D at baseline
Folate	Moderate—reduced intake + absorption	6–12 months	Red blood cell folate or serum folate at baseline and 6 months
Vitamin D	Moderate—reduced fat intake	3–6 months	25-OH vitamin D at baseline and 6-month recheck

Genetic Predispositions and Individual Micronutrient Risk

Your genes influence how efficiently you absorb B12, how you metabolize folate, and how your body regulates iron homeostasis. Some individuals carry genetic variants that predispose them to faster micronutrient depletion, even without GLP-1 therapy. Semaglutide may amplify these baseline risks.

The PlexusDx Precision Peptide Genetic Test can reveal predispositions in pathways affecting nutrient metabolism and GLP-1 response. This context—combined with baseline micronutrient blood work—may help your provider tailor supplementation strategy rather than guessing which vitamins you actually need.

Practical Supplementation Strategy and Safety Considerations

Start with blood work before beginning compounded semaglutide. Establish your baseline B12, iron panel, calcium, vitamin D, and folate status. This prevents over-supplementing nutrients you don't need while identifying deficiencies that require higher doses or different delivery formats (sublingual B12, intravenous iron, etc.).

Timing matters: separate calcium and iron supplements from each other and from semaglutide dosing by at least 2–4 hours, as they compete for absorption. Take B12 sublingually or via injection if gastric acid is already compromised. Work with your provider to recheck labs every 3–6 months and adjust your regimen based on actual blood values, not assumptions.

How PlexusDx Supports a More Personalized Approach

PlexusDx believes personalized micronutrient strategy should reflect your individual baseline status, genetic predispositions, and the specific demands of compounded semaglutide therapy. Rather than recommend generic multivitamins, we encourage patients to partner with their provider on a data-driven approach. This may help provide context for which supplements deserve your attention and investment.

The Precision Peptide Genetic Test reveals predispositions in nutrient metabolism and absorption pathways relevant to GLP-1 use. Variants in folate metabolism (MTHFR), B12 transport, and iron regulation can influence your individual micronutrient needs. This genetic insight should be interpreted with your qualified healthcare provider and combined with blood work to guide supplementation decisions.

Understanding your genetic context plus your baseline lab values empowers a conversation with your provider about whether you need aggressive B12 replacement, iron supplementation, or higher-dose calcium before deficiency symptoms emerge. This precision-wellness strategy is more efficient and evidence-based than broad supplementation for all semaglutide users.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Oral is $349/mo month-to-month, or from $279/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Why does this article treat micronutrient status as something worth checking?

Because intake falls sharply. Its central point is that a much smaller volume of food means fewer absolute nutrients arriving, regardless of how well any single nutrient is absorbed. It says bloodwork after three to six months on treatment often turns up deficiencies in people who have not addressed nutrition deliberately, which is the basis of its argument for measuring rather than assuming.

Which nutrients does the article flag as the highest priority to monitor?

Its framework puts vitamin B12 and iron at the top as high risk, with calcium, folate and vitamin D listed as moderate. It pairs each with a monitoring test rather than a supplement: serum B12 or methylmalonic acid, ferritin with serum iron and TIBC, 25-OH vitamin D, and red blood cell or serum folate. The emphasis throughout is on measuring before acting.

When does the article say nutrient deficiencies typically start to appear?

It gives different windows by nutrient. Iron and vitamin D are placed on a three to six month timeline, while B12, calcium and folate are placed at six to twelve months. The article uses those windows to argue for baseline testing before treatment begins, so that a decline shows up on a lab report at a predictable point rather than being discovered through symptoms.

Why does the article argue against simply taking a general multivitamin?

Because it wants supplementation matched to measured status rather than assumed need. It says establishing a baseline first avoids loading up on nutrients that were never low, while identifying the ones that genuinely require attention and possibly a different delivery format. Its position is that what to take, in what form and at what level is a decision for a provider reading your actual blood values.

How often does the article suggest lab values be rechecked during treatment?

Every three to six months, working with a provider and adjusting based on measured values rather than assumptions. Rechecks are also built into its nutrient table, with B12 and folate suggested at baseline and around six months and iron studies at baseline and three months. The recurring theme is that supplement decisions follow the labs rather than leading them.

Related Reading

• Semaglutide Providers That Take Fsa Plexusdx
• Does My Dna Determine How Well I Absorb Vitamins And Minerals
• Medvi Semaglutide
• Bioverse Semaglutide

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.